Clinical Trial Update: Axitinib and Oral Metronomic Etoposide for Pediatric Children and AYA Refractory/Relapsing Medulloblastoma and Ependymoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of axitinib combined with oral metronomic etoposide for pediatric and adolescent/young adult patients with relapsed/refractory medulloblastoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ependymoma
• Medulloblastoma

Drugs mentioned

• Axitinib (Axitinib)
• Etoposide (Etoposide)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Medulloblastoma, Ependymoma | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING